Cargando…
Saracatinib Fails to Reduce Alcohol-Seeking and Consumption in Mice and Human Participants
More effective treatments to reduce pathological alcohol drinking are needed. The glutamatergic system and the NMDA receptor (NMDAR), in particular, are implicated in behavioral and molecular consequences of chronic alcohol use, making the NMDAR a promising target for novel pharmacotherapeutics. Eth...
Autores principales: | Thompson, Summer L., Gianessi, Carol A., O'Malley, Stephanie S., Cavallo, Dana A., Shi, Julia M., Tetrault, Jeanette M., DeMartini, Kelly S., Gueorguieva, Ralitza, Pittman, Brian, Krystal, John H., Taylor, Jane R., Krishnan-Sarin, Suchitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438169/ https://www.ncbi.nlm.nih.gov/pubmed/34531767 http://dx.doi.org/10.3389/fpsyt.2021.709559 |
Ejemplares similares
-
Association of Vaping and Respiratory Health among Youth in the Population Assessment of Tobacco and Health (PATH) Study Wave 3
por: Cherian, Christie, et al.
Publicado: (2021) -
Treatment Implications: Using Neuroscience to Guide the Development of New Pharmacotherapies for Alcoholism
por: Krishnan-Sarin, Suchitra, et al.
Publicado: (2008) -
Longitudinal Trajectories of Multiple Nicotine Product Use Among Youths in the Population Assessment of Tobacco and Health Study
por: Simon, Patricia, et al.
Publicado: (2022) -
NMDA Glutamate Receptor Antagonism and the Heritable Risk for Alcoholism: New Insights from a Study of Nitrous Oxide
por: Krystal, John H, et al.
Publicado: (2017) -
Trajectories of relapse in randomized placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient level data meta-analysis
por: Gueorguieva, Ralitza, et al.
Publicado: (2017)